Revenue Growth
Second quarter revenue totaled $222.9 million, reflecting a 5.4% increase in organic revenue and a 7.6% increase in total revenue versus Q2 2024.
Medical Segment Performance
The Medical segment was a positive contributor with organic revenue growth across all three medical end markets, leading to a 20% increase in adjusted EBITDA.
Nuclear Power Market Expansion
Increased 2025 organic growth expectations for the Nuclear Power sector, with double-digit organic growth expected from Nuclear Power versus high single digit previously.
Acquisition of Certrec
Announced the acquisition of Certrec, a leading provider of regulatory compliance solutions to the U.S. nuclear industry, expected to enhance growth with commercial synergies.
Improved Capital Structure
Completed a $400 million convertible note offering and refinanced a term loan, providing flexibility for further capital deployment and lowering the total cost of capital.